STRYKER CORP shareholders Q2 2022

STRYKER CORP's ticker is SYK and the CUSIP is 863667101. A total of 1,558 filers reported holding STRYKER CORP in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.

STRYKER CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CONCENTRIC WEALTH MANAGEMENT, LLC 17,451$3,472,0001.17%
Alley Investment Management Company, LLC 30,929$6,153,0001.16%
Covington Investment Advisors Inc. 22,861$4,548,0001.15%
FARMERS TRUST CO 23,993$4,773,0001.14%
Aevitas Wealth Management, Inc. 8,439$1,679,0001.14%
FIRST MERCHANTS CORP 57,351$11,409,0001.13%
MOODY LYNN & LIEBERSON, LLC 61,988$12,331,0001.11%
INVESTMENT ADVISORY SERVICES INC /TX /ADV 9,587$1,907,0001.10%
CapWealth Advisors, LLC 45,825$9,116,0001.10%
BURNS J W & CO INC/NY 29,141$5,797,0001.10%
YHB Investment Advisors, Inc. 52,318$10,408,0001.10%
Covington Capital Management 134,146$26,686,0001.08%
LYNCH & ASSOCIATES/IN 20,023$3,983,0001.08%
Mendel Capital Management LLC 4,794$954,0001.07%
Baker Chad R 19,145$3,809,0001.06%
FCA CORP /TX 13,475$2,681,0001.06%
EFG Asset Management (North America) Corp. 25,152$5,007,0001.05%
Palisade Asset Management, LLC 41,250$8,206,0001.05%
BOSTON FAMILY OFFICE LLC 63,362$12,605,0001.05%
Brightworth 49,346$9,816,0001.05%
About STRYKER CORP

Stryker Corp is a leading medical technology company that specializes in developing and manufacturing medical devices and equipment. The company has a strong reputation for innovation and has been at the forefront of developing new technologies that have revolutionized the healthcare industry.

Stryker Corp's product portfolio includes a wide range of medical devices and equipment, including surgical instruments, orthopedic implants, and medical imaging systems. The company's products are used in hospitals, clinics, and other healthcare facilities around the world.

One of the key strengths of Stryker Corp is its focus on research and development. The company invests heavily in R&D, and this has enabled it to develop a number of groundbreaking technologies that have helped to improve patient outcomes and reduce healthcare costs.

Another key strength of Stryker Corp is its strong financial position. The company has a solid balance sheet and generates strong cash flows, which has enabled it to invest in new technologies and pursue strategic acquisitions.

Looking ahead, Stryker Corp is well-positioned to continue to grow and expand its business. The company has a strong pipeline of new products and technologies, and is well-positioned to benefit from the growing demand for medical devices and equipment around the world.

Overall, Stryker Corp is a well-managed and innovative company that is poised for continued success in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists STRYKER CORP's shareholders in Q2 2022. To view STRYKER CORP's shareholder history, click here.